Copyright Reports & Markets. All rights reserved.

Global Immunohistochemistry（IHC） Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Immunohistochemistry（IHC） Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Traditional Direct Method
    • 1.3.3 New Direct Method
    • 1.3.4 Enzyme Bridgemethod
    • 1.3.5 PAP Method
  • 1.4 Market by Application
    • 1.4.1 Global Immunohistochemistry（IHC） Testing Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Corporation
    • 1.4.5 Other
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Immunohistochemistry（IHC） Testing Market Perspective (2015-2026)
  • 2.2 Immunohistochemistry（IHC） Testing Growth Trends by Regions
    • 2.2.1 Immunohistochemistry（IHC） Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Immunohistochemistry（IHC） Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Immunohistochemistry（IHC） Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Immunohistochemistry（IHC） Testing Industry Dynamic
    • 2.3.1 Immunohistochemistry（IHC） Testing Market Trends
    • 2.3.2 Immunohistochemistry（IHC） Testing Market Drivers
    • 2.3.3 Immunohistochemistry（IHC） Testing Market Challenges
    • 2.3.4 Immunohistochemistry（IHC） Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Immunohistochemistry（IHC） Testing Players by Market Size
    • 3.1.1 Global Top Immunohistochemistry（IHC） Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Immunohistochemistry（IHC） Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Immunohistochemistry（IHC） Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Immunohistochemistry（IHC） Testing Revenue
  • 3.4 Global Immunohistochemistry（IHC） Testing Market Concentration Ratio
    • 3.4.1 Global Immunohistochemistry（IHC） Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Immunohistochemistry（IHC） Testing Revenue in 2019
  • 3.5 Key Players Immunohistochemistry（IHC） Testing Area Served
  • 3.6 Key Players Immunohistochemistry（IHC） Testing Product Solution and Service
  • 3.7 Date of Enter into Immunohistochemistry（IHC） Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Immunohistochemistry（IHC） Testing Breakdown Data by Type

  • 4.1 Global Immunohistochemistry（IHC） Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Immunohistochemistry（IHC） Testing Forecasted Market Size by Type (2021-2026)

5 Immunohistochemistry（IHC） Testing Breakdown Data by Application

  • 5.1 Global Immunohistochemistry（IHC） Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Immunohistochemistry（IHC） Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Immunohistochemistry（IHC） Testing Market Size (2015-2026)
  • 6.2 North America Immunohistochemistry（IHC） Testing Market Size by Type (2015-2020)
  • 6.3 North America Immunohistochemistry（IHC） Testing Market Size by Application (2015-2020)
  • 6.4 North America Immunohistochemistry（IHC） Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Immunohistochemistry（IHC） Testing Market Size (2015-2026)
  • 7.2 Europe Immunohistochemistry（IHC） Testing Market Size by Type (2015-2020)
  • 7.3 Europe Immunohistochemistry（IHC） Testing Market Size by Application (2015-2020)
  • 7.4 Europe Immunohistochemistry（IHC） Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Immunohistochemistry（IHC） Testing Market Size (2015-2026)
  • 8.2 Asia-Pacific Immunohistochemistry（IHC） Testing Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Immunohistochemistry（IHC） Testing Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Immunohistochemistry（IHC） Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Immunohistochemistry（IHC） Testing Market Size (2015-2026)
  • 9.2 Latin America Immunohistochemistry（IHC） Testing Market Size by Type (2015-2020)
  • 9.3 Latin America Immunohistochemistry（IHC） Testing Market Size by Application (2015-2020)
  • 9.4 Latin America Immunohistochemistry（IHC） Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Immunohistochemistry（IHC） Testing Market Size (2015-2026)
  • 10.2 Middle East & Africa Immunohistochemistry（IHC） Testing Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Immunohistochemistry（IHC） Testing Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Immunohistochemistry（IHC） Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11 Key Players Profiles

  • 11.1 University of Texas MD Anderson Cancer Center
    • 11.1.1 University of Texas MD Anderson Cancer Center Company Details
    • 11.1.2 University of Texas MD Anderson Cancer Center Business Overview
    • 11.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry（IHC） Testing Introduction
    • 11.1.4 University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020))
    • 11.1.5 University of Texas MD Anderson Cancer Center Recent Development
  • 11.2 Memorial Sloan Kettering Cancer Center
    • 11.2.1 Memorial Sloan Kettering Cancer Center Company Details
    • 11.2.2 Memorial Sloan Kettering Cancer Center Business Overview
    • 11.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry（IHC） Testing Introduction
    • 11.2.4 Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.2.5 Memorial Sloan Kettering Cancer Center Recent Development
  • 11.3 Mayo Clinic
    • 11.3.1 Mayo Clinic Company Details
    • 11.3.2 Mayo Clinic Business Overview
    • 11.3.3 Mayo Clinic Immunohistochemistry（IHC） Testing Introduction
    • 11.3.4 Mayo Clinic Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.3.5 Mayo Clinic Recent Development
  • 11.4 Johns Hopkins Hospital
    • 11.4.1 Johns Hopkins Hospital Company Details
    • 11.4.2 Johns Hopkins Hospital Business Overview
    • 11.4.3 Johns Hopkins Hospital Immunohistochemistry（IHC） Testing Introduction
    • 11.4.4 Johns Hopkins Hospital Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.4.5 Johns Hopkins Hospital Recent Development
  • 11.5 Cleveland Clinic
    • 11.5.1 Cleveland Clinic Company Details
    • 11.5.2 Cleveland Clinic Business Overview
    • 11.5.3 Cleveland Clinic Immunohistochemistry（IHC） Testing Introduction
    • 11.5.4 Cleveland Clinic Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.5.5 Cleveland Clinic Recent Development
  • 11.6 Dana-Farber/Brigham and Women's Cancer Center
    • 11.6.1 Dana-Farber/Brigham and Women's Cancer Center Company Details
    • 11.6.2 Dana-Farber/Brigham and Women's Cancer Center Business Overview
    • 11.6.3 Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry（IHC） Testing Introduction
    • 11.6.4 Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.6.5 Dana-Farber/Brigham and Women's Cancer Center Recent Development
  • 11.7 Cedars-Sinai Medical Center
    • 11.7.1 Cedars-Sinai Medical Center Company Details
    • 11.7.2 Cedars-Sinai Medical Center Business Overview
    • 11.7.3 Cedars-Sinai Medical Center Immunohistochemistry（IHC） Testing Introduction
    • 11.7.4 Cedars-Sinai Medical Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.7.5 Cedars-Sinai Medical Center Recent Development
  • 11.8 Northwestern Memorial Hospital
    • 11.8.1 Northwestern Memorial Hospital Company Details
    • 11.8.2 Northwestern Memorial Hospital Business Overview
    • 11.8.3 Northwestern Memorial Hospital Immunohistochemistry（IHC） Testing Introduction
    • 11.8.4 Northwestern Memorial Hospital Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.8.5 Northwestern Memorial Hospital Recent Development
  • 11.9 Seattle Cancer Care Alliance/University of Washington Medical Center
    • 11.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Company Details
    • 11.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview
    • 11.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry（IHC） Testing Introduction
    • 11.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Development
  • 11.10 University of California San Francisco Medical Center
    • 11.10.1 University of California San Francisco Medical Center Company Details
    • 11.10.2 University of California San Francisco Medical Center Business Overview
    • 11.10.3 University of California San Francisco Medical Center Immunohistochemistry（IHC） Testing Introduction
    • 11.10.4 University of California San Francisco Medical Center Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 11.10.5 University of California San Francisco Medical Center Recent Development
  • 11.11 CancerResearchUK
    • 10.11.1 CancerResearchUK Company Details
    • 10.11.2 CancerResearchUK Business Overview
    • 10.11.3 CancerResearchUK Immunohistochemistry（IHC） Testing Introduction
    • 10.11.4 CancerResearchUK Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 10.11.5 CancerResearchUK Recent Development
  • 11.12 Pfizer
    • 10.12.1 Pfizer Company Details
    • 10.12.2 Pfizer Business Overview
    • 10.12.3 Pfizer Immunohistochemistry（IHC） Testing Introduction
    • 10.12.4 Pfizer Revenue in Immunohistochemistry（IHC） Testing Business (2015-2020)
    • 10.12.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Immunohistochemistry（IHC） Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunohistochemistry（IHC） Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Traditional Direct Method
    New Direct Method
    Enzyme Bridgemethod
    PAP Method

    Market segment by Application, split into
    Hospital
    Research Institute
    Corporation
    Other

    Based on regional and country-level analysis, the Immunohistochemistry（IHC） Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Immunohistochemistry（IHC） Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    University of Texas MD Anderson Cancer Center
    Memorial Sloan Kettering Cancer Center
    Mayo Clinic
    Johns Hopkins Hospital
    Cleveland Clinic
    Dana-Farber/Brigham and Women's Cancer Center
    Cedars-Sinai Medical Center
    Northwestern Memorial Hospital
    Seattle Cancer Care Alliance/University of Washington Medical Center
    University of California San Francisco Medical Center
    CancerResearchUK

    Buy now